1. Home
  2. ITRN vs VTYX Comparison

ITRN vs VTYX Comparison

Compare ITRN & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

N/A

Current Price

$47.45

Market Cap

881.7M

Sector

Technology

ML Signal

N/A

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

N/A

Current Price

$13.97

Market Cap

990.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRN
VTYX
Founded
1994
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
881.7M
990.9M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
ITRN
VTYX
Price
$47.45
$13.97
Analyst Decision
Buy
Hold
Analyst Count
1
7
Target Price
$50.00
$13.50
AVG Volume (30 Days)
65.0K
2.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.21%
N/A
EPS Growth
N/A
40.30
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.12
N/A
Revenue Next Year
$10.70
N/A
P/E Ratio
$16.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.23
$0.90
52 Week High
$49.72
$15.34

Technical Indicators

Market Signals
Indicator
ITRN
VTYX
Relative Strength Index (RSI) 54.44 72.34
Support Level $35.09 $13.89
Resistance Level N/A $14.07
Average True Range (ATR) 1.38 0.03
MACD -0.09 -0.13
Stochastic Oscillator 46.31 92.86

Price Performance

Historical Comparison
ITRN
VTYX

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: